Brain‐Derived Neurotrophic Factor Prevents Human Immunodeficiency Virus Type 1 Protein gp120 Neurotoxicity in the Rat Nigrostriatal System
- 10 December 2007
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1122 (1) , 144-154
Abstract
Human immunodeficiency virus type 1 (HIV-1) causes neuronal degeneration and, at a late stage, creates HIV-associated dementia (HAD) and other neurological abnormalities. Therefore, the need for neuroprotective agents is great. However, therapeutic agents that reduce HIV neurotoxicity are difficult to characterize and develop because rodents are not infected by HIV. This study was undertaken to develop an animal model of HIV neurotoxicity by using the HIV-1 envelope glycoprotein 120 (gp120). Vehicle or gp120 was injected acutely in the striatum of adult rats. gp120 produced loss of nigrostriatal neurons, as shown both by histochemical analysis of brain sections for apoptosis and biochemical determination of dopamine. The neurotrophin brain-derived neurotrophic factor (BDNF) delivered by a recombinant adeno-associated viral vector prevented gp120 toxicity. This study's results support the notion that gp120 produces a widespread neurotoxicity similar to that observed in HIV-positive individuals and that BDNF may be a suitable neuroprotective agent for HAD.Keywords
This publication has 44 references indexed in Scilit:
- Brain‐derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus‐1 glycoprotein 120 in vivoEuropean Journal of Neuroscience, 2007
- Axonal Transport of Human Immunodeficiency Virus Type 1 Envelope Protein Glycoprotein 120 Is Found in Association with Neuronal ApoptosisThe Journal of Neuroscience, 2006
- Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus‐gp120‐mediated apoptosisJournal of Neuroscience Research, 2006
- Effects of 4′-Chloro-3α-(diphenylmethoxy)-tropane on Mesostriatal, Mesocortical, and Mesolimbic Dopamine Transmission: Comparison with Effects of CocaineThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain‐derived neurotrophic factor in vivo: potential implication for neuronal cell deathEuropean Journal of Neuroscience, 2004
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Role of the α‐chemokine stromal cell‐derived factor (SDF‐1) in the developing and mature central nervous systemGlia, 2003
- Parkinsonism in HIV dementiaJournal of Neural Transmission, 2002
- Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4Current Biology, 1998
- Ascending Systems of Catecholamine Neurons from the Lower Brain StemActa Physiologica Scandinavica, 1964